| Name | Vorolanib |
|---|---|
| Synonyms |
CM-082
VEGFR,PDGFR,X82,Vasculendothelial owth factor rector,CM 082,transporter,angiogenesis,CM-082,X 82,Vorolanib,ATP-binding,tyrosine,ABC,Inhibitor,ABCG2,inhibit,Platelet-derived owth factor rector,TKI,cassette,orally,kinase,HUVECs (S,Z)-N-(1-(Dimethylcbamoyl)pyrrolidin-3-yl)-5-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-cboxamide X-82 X 82 X-82 (Vorolanib) Vorolanib, 10 mM in DMSO 1H-Pyrrole-3-cboxamide, N-[(3S)-1-[(dimethylamino)carbonyl]-3-pyrrolidinyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl CM082 X82 (S,Z)-N-[1-(Dimethylcbamoyl)-3-pyrrolidinyl]-5-[(5-fluoro-2-oxoindolin-3-ylidene)methyl]-2,4-dimethylpyrrole-3-cboxamide CM 082 X-082 |
| Description | Vorolanib (CM082; X-82) is an orally active, multikinase VEGFR/PDGFR inhibitor. Vorolanib minimizes toxicity, disrupts tumor angiogenesis and tumor cell proliferation, and induces of tumor cell death[1]. |
|---|---|
| Related Catalog | |
| Target |
VEGFR, PDGFR[1] |
| References |
| Molecular Formula | C23H26FN5O3 |
|---|---|
| Molecular Weight | 439.48 |